Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Res ; 35(5): 2565-70, 2015 May.
Article in English | MEDLINE | ID: mdl-25964531

ABSTRACT

BACKGROUND/AIM: Prostate cancer (PCa) shows disproportionately higher incidence and disease-associated mortality in African Americans. The human crystallin beta B2 (CRYBB2) gene has been reported as one tumor signature gene differentially expressed between African American and European American cancer patients. We investigated the role of CRYBB2 genetic variants in PCa in African Americans. MATERIALS AND METHODS: Subjects comprised of 233 PCa cases and 294 controls. Nine haplotype-tagged single nucleotide polymorphisms (SNPs) in and around the CRYBB2 gene were genotyped by pyrosequencing. Association analyses were performed for PCa with adjustment for age and prostate-specific antigen (PSA), under an additive genetic model. RESULTS: Out of the nine SNPs examined, rs9608380 was found to be nominally associated with PCa (odds ratio (OR)=2.619 (95% confidence interval (CI)=1.156-5.935), p=0.021). rs9306412 was in strong linkage disequilibrium with rs9608380 that showed an association p-value of 0.077. Using ENCODE data, we found rs9608380 mapped to a region annotated with regulatory motifs, such as DNase hypersensitive sites and histone modifications. CONCLUSION: This is the first study to analyze the association between genetic variations in the CRYBB2 gene with PCa. rs9608380, associated with PCa, is a potentially functional variant.


Subject(s)
Prostatic Neoplasms/genetics , beta-Crystallin B Chain/genetics , Adult , Aged , Genetic Association Studies , Genetic Predisposition to Disease , Haplotypes , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Prostate-Specific Antigen/genetics , Prostatic Neoplasms/pathology , Risk Factors
2.
J Racial Ethn Health Disparities ; 2(3): 295-302, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26863460

ABSTRACT

OBJECTIVE: To investigate the clinical characteristics and treatment patterns for African-American (AA) men with low-risk prostate cancer (PCa) using a national, population-based dataset. METHODS: We conducted a retrospective review of the Surveillance Epidemiology and End Results database 2004-2008. AA men aged ≥40 years with low-risk PCa were identified. For comparison, white men were selected using the same selection criteria. We reviewed all recorded treatment modalities. Definitive treatment (DT) was defined as undergoing radiotherapy or prostatectomy. RESULTS: Overall, 7246 AA men and 47,154 white men met the criteria. Most of the patients had PSA level between 4.1 and 6.9 ng/mL (56.2 %) and received DT (76 %). Black men were younger (mean age: 62(±8) vs. 65(±10) years), less likely to receive DT (adjusted odds ratio (AOR), 0.71 [0.67-0.76]), and of those receiving DT, less likely to undergo prostatectomy (AOR, 0.58 [0.54-0.62]). Patients receiving DT had lower crude cancer-specific and overall mortality (0.17 vs. 0.41 % and 2.9 vs. 7.8 %, p value < 0.001, respectively, among blacks). The difference in overall mortality was largest among ≥ 75 years (5.6 vs. 18.2 %). Across age groups, blacks had higher all-cause mortality (AOR, 1.45 [1.13-1.87] and 1.56[1.31-1.86] for <65 and ≥ 65 years, respectively). CONCLUSION: Our study of a large modern cohort of men with low-risk PCa demonstrates significant lower receipt of DT, lower receipt of prostatectomy among those receiving DT, and lower survival for black men compared to their white counterparts. Older men were less likely to receive DT. Patients who received DT had better survival. The survival difference was most striking among the elderly.


Subject(s)
Black or African American/statistics & numerical data , Prostatic Neoplasms/ethnology , Prostatic Neoplasms/therapy , Adult , Aged , Databases, Factual , Health Status Disparities , Humans , Male , Middle Aged , Retrospective Studies , Risk Assessment , Treatment Outcome , United States , White People/statistics & numerical data
3.
JSLS ; 18(3)2014.
Article in English | MEDLINE | ID: mdl-25392666

ABSTRACT

BACKGROUND AND OBJECTIVES: Ureteral injury is an infrequent but potentially lethal complication of colectomy. We aimed to determine the incidence of intraoperative ureteral injury after laparoscopic and open colectomy and to determine the independent morbidity and mortality rates associated with ureteral injury. METHODS: We analyzed data from the National Surgical Quality Improvement Program for the years 2005-2010. All patients undergoing colectomy for benign, neoplastic, or inflammatory conditions were selected. Patients undergoing laparoscopic colectomy versus open colectomy were matched on disease severity and clinical and demographic characteristics. Multivariate logistic regression analyses and coarsened exact matching were used to determine the independent difference in the incidence of ureteral injury between the 2 groups. Multivariate models were also used to determine the independent association between postoperative complications associated with ureteral injury. RESULTS: Of a total of 94,526 colectomies, 33,092 (35%) were completed laparoscopically. Ureteral injury occurred in a total of 585 patients (0.6%). The crude incidence in the open group was higher than that in the laparoscopic group (0.66% versus 0.53%, P=.016). CEM produced 14 630 matching pairs. Matched analysis showed the likelihood of ureteral injury after laparoscopic colectomy to be 30% less than after open colectomy (odds ratio, 0.70; 95% confidence interval, 0.51-0.96). Patients with ureteral injury were independently more likely to have septic complications and have longer lengths of hospital stay than those without ureteral injury. CONCLUSION: Laparoscopic colectomy is associated with a lower incidence of intraoperative ureteral injury when compared with open procedures. Ureteral injury leads to significant postoperative morbidity even if identified and repaired during the colectomy.


Subject(s)
Colectomy/adverse effects , Laparoscopy/adverse effects , Postoperative Complications/epidemiology , Ureter/injuries , Adolescent , Adult , Aged , Child , Child, Preschool , Colectomy/methods , Female , Humans , Incidence , Infant , Infant, Newborn , Laparoscopy/methods , Male , Middle Aged , Odds Ratio , United States/epidemiology , Young Adult
4.
BMJ Case Rep ; 20132013 Feb 15.
Article in English | MEDLINE | ID: mdl-23417949

ABSTRACT

Involvement of the genitourinary tract by sarcoidosis may present with a scrotal mass, mimicking infection or malignancy. Sarcoidosis is a systemic granulomatous disease that affects patients of both sexes worldwide. Sarcoidosis of the genitourinary tract is rare. We describe a case of a 33-year-old African-American man who presents with a scrotal mass, mediastinal mass, unilateral lung masses and pleural effusion mimicking testicular malignancy with pulmonary metastases. The histopathological examination of the right testis and lung biopsy revealed granulomatous inflammation consistent with sarcoidosis. Genitourinary sarcoidosis must be a diagnostic consideration, especially in an African-American patient with a scrotal mass. There is a possible association between sarcoidosis and testicular malignancy; hence, underlying malignancy should always be ruled out. Serum tumour markers, ACE, a biopsy of the accessible tissue and intraoperative frozen section analysis aid in establishing the diagnosis of sarcoidosis and leading to appropriate management.


Subject(s)
Lung Neoplasms/diagnosis , Pleural Effusion/etiology , Sarcoidosis/pathology , Testicular Diseases/pathology , Testicular Neoplasms/diagnosis , Testis/pathology , Adult , Biopsy , Diagnosis, Differential , Humans , Lung Neoplasms/secondary , Male , Pleural Effusion/diagnosis , Sarcoidosis/complications , Testicular Diseases/complications , Testicular Neoplasms/secondary
5.
Hum Genet ; 120(1): 69-76, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16733712

ABSTRACT

Intercellular adhesion molecules (ICAMs) are known to be involved in various human cancers. An ICAM gene cluster lying within a 26 kb region on chromosome 19p13.2, and containing ICAM1, ICAM4, and ICAM5 has recently been identified as harboring a breast and prostate cancer susceptibility locus in two populations of European ancestry from Germany and Australia. The objective of this study was to confirm the ICAM association with prostate cancer in a sample of African American prostate cancer cases (N = 286) and controls (N = 391). Six single nucleotide polymorphisms (SNPs) within the three ICAM genes were genotyped. To control for potential population stratification an ancestry-adjusted association analysis was performed. We found that ICAM1 SNPs, -9A/C (rs5490) and K469E (rs5498) were associated with prostate cancer risk in men with a family history of prostate cancer (P = 0.008). Specifically, increased risk was observed for individuals who possessed the CC genotype of the -9 A/C variant (odds ratio = 2.5; 95% CI = 1.0-6.3) and at least one G allele of non-synonymous K469E variant (odds ratio = 1.8; 95% CI = 1.2-3.1). Strong linkage disequilibrium was observed across the ICAM region (P < 0.001). A common haplotype within the ICAM gene cluster, harboring the -9A/C variant was significantly associated with prostate cancer (P = 0.03), mainly due to men with family history (P = 0.01). Our results replicate previous findings of association of the ICAM gene cluster with prostate cancer and suggest that common genetic variation within ICAM1 and not ICAM5 may be an important risk factor for prostate cancer.


Subject(s)
Black or African American/genetics , Cell Adhesion Molecules/genetics , Multigene Family/genetics , Polymorphism, Single Nucleotide , Prostatic Neoplasms/genetics , Aged , Gene Frequency , Genotype , Haplotypes , Humans , Intercellular Adhesion Molecule-1/genetics , Linkage Disequilibrium , Logistic Models , Male , Membrane Glycoproteins/genetics , Middle Aged , Nerve Tissue Proteins/genetics , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Risk Factors
6.
Urology ; 64(1): 156-8, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15245961

ABSTRACT

The incidence of tuberculosis in the United States is on the rise, in part, because of its association with acquired immunodeficiency syndrome. Genitourinary tuberculosis remains one of the most common forms of secondary or extrapulmonary disease. We present an unusual case of tuberculous epididymitis with extensive retroperitoneal and mediastinal spread. The possible routes of dissemination, as well as the efficacy of antimycobacterial therapy in the management of tuberculous epididymitis, are discussed and the relevant literature is reviewed.


Subject(s)
Epididymitis/diagnosis , Tuberculosis, Male Genital/diagnosis , Adult , Antitubercular Agents/therapeutic use , Diagnostic Imaging , District of Columbia , Drug Therapy, Combination , Epididymitis/drug therapy , Epididymitis/microbiology , Epididymitis/pathology , Humans , Isoniazid/therapeutic use , Male , Mediastinum/pathology , Pyrazinamide/therapeutic use , Retroperitoneal Space , Rifampin/therapeutic use , Sierra Leone/ethnology , Tuberculosis, Male Genital/drug therapy , Tuberculosis, Male Genital/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...